肺叶切除较高风险IA期非小细胞肺癌亚肺叶切除改善无病生存
本研究基于前瞻性数据库,比较临床T1a-T1bN0M0(≤2 cm)非小细胞肺癌行肺叶切除与亚肺叶切除的无病生存(DFS),采用1:1倾向性匹配平衡高危特征。匹配后5年DFS(85% vs 74%,P = .12)无显著差异,但存在2个及以上高危特征时亚肺叶切除的DFS更差。结论提示多高危特征的≤2 cm IA期NSCLC应考虑肺叶切除。
要点
- 匹配队列5年DFS肺叶切除85% vs 亚肺叶切除74%,P = .12。
- 肺叶切除组N1升期比例更高(9.1% vs 3.4%,P = .004)。
- 2个高危特征时亚肺叶切除复发风险HR 1.77(95%CI 1.13-2.76,P = .012)。
核心结论
- 对于≤2 cm的IA期NSCLC,存在多个高危特征时肺叶切除应优先于亚肺叶切除。
研究设计与样本
- 基于前瞻性数据库的倾向性匹配队列研究,纳入临床T1a-T1bN0M0(≤2 cm)NSCLC患者825例,其中肺叶切除426例(52%)、亚肺叶切除399例(48%)。
主要发现
- 匹配前肺叶切除组具有更多高危特征:cT1b、更高SUV、实性纹理、微乳头/实性组织学(均P < .001)。
- 匹配队列660例中,肺叶切除组N1升期比例更高(9.1% vs 3.4%,P = .004)。
- 匹配队列5年DFS肺叶切除85% vs 亚肺叶切除74%(P = .12)。
- 亚肺叶切除患者中,2个高危特征者DFS更差(HR 1.77,95%CI 1.13-2.76,P = .012)。
- 3-4个高危特征者亚肺叶切除DFS更差(HR 1.97,95%CI 1.25-3.10,P = .004)。
关键数值与推荐
- 高危特征包括:cT1b vs cT1a、原发肿瘤PET标准摄取值、CT实性 vs 亚实性纹理、微乳头/实性组织学。
- 亚肺叶切除中45%为肺段切除、55%为楔形切除。
临床怎么用
- 对于≤2 cm的IA期NSCLC,应评估高危特征数量,存在2个及以上高危特征时优先考虑肺叶切除。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate disease-free survival (DFS) of sublobar resection versus lobectomy for stage IA non-small cell lung cancer (NSCLC) with preoperative high-risk features. METHODS: Data were abstracted from a prospective database to identify patients with clinical T1a-T1bN0M0 NSCLC (≤2 cm) who underwent lobectomy or sublobar resection (wedge resection or segmentectomy). 1:1 propensity matching was used to balance the dataset for forced expiratory volume in 1 second ≥60% and high-risk features: cT1b versus cT1a, standard uptake value of the primary tumor on positron emission tomography, solid versus subsolid tumor texture on computed tomography, and micropapillary/solid histology. The primary outcome was DFS. RESULTS: In total, 825 patients met inclusion criteria: 52% (n = 426) patients underwent lobectomy and 48% (n = 399) of patients underwent sublobar resection (45% segmentectomy, 55% wedge resection). Lobectomy was associated with more preoperative high-risk features: cT1b (P < .001), greater standard uptake value (P < .001), solid tumor texture on computed tomography (P < .001), and micropapillary/solid histology (P < .001). In total, 660 patients were included in the matched analysis with all high-risk features balanced. Nodal upstaging (N1) was greater in patients who underwent lobectomy (9.1% vs 3.4%, P = .004). Five-year DFS (85% vs 74%, P = .12) was equivalent in the matched cohort. Lobectomy was protective for recurrence in the presence of 2 or greater high-risk features: sublobar resection patients with 2 high-risk features (hazard ratio, 1.77; 95% confidence interval, 1.13-2.76, P = .012) or 3-4 high-risk features (hazard ratio, 1.97; 95% confidence interval, 1.25-3.10, P = .004) had worse DFS. CONCLUSIONS: Lobectomy should be considered over sublobar resection for stage IA NSCLC ≤2 cm in the presence of multiple high-risk features.
引用
- Caso R, Zhou N, Skovgard M, et al. Lobectomy improves disease-free survival over sublobar resection for high-risk stage IA non-small cell lung cancer. J Thorac Cardiovasc Surg. 2025. PMID: 40886909. doi:10.1016/j.jtcvs.2025.08.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。